Related Experiment Video
Updated: May 28, 2025
08:39
Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
4.5K
Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing
Runze Liu1, Yong Zhang2, Zhongbao Zhou1
1Department of Urology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Urologia Internationalis
|February 10, 2025
Summary
Patient-derived organoids (PDOs) offer a promising new model for bladder cancer research. This study successfully established a bladder PDO culture system, paving the way for precision medicine approaches.
Area of Science:
- Uro-oncology
- Cancer biology
- Regenerative medicine
Background:
- Bladder urothelial carcinoma presents significant heterogeneity and recurrence challenges.
- Current intravesical therapies necessitate reliable tumor models for personalized treatment.
- Patient-derived organoids (PDOs) represent advanced, accurate models overcoming traditional limitations.
Purpose of the Study:
- To establish a viable culture system for bladder cancer patient-derived organoids (PDOs).
- To validate PDOs as accurate preclinical models for bladder cancer.
- To explore the utility of PDOs in guiding precision medicine strategies.
Main Methods:
- Bladder cancer tissues were sourced from surgical resections (September 2023 - February 2024).
- Primary tumor cells were cultured using Matrigel matrix gels.
- Histological validation via Hematoxylin and eosin (HE) staining and immunohistochemistry was performed.
- Drug sensitivity assays were conducted on established PDOs.
Main Results:
- A robust culture system for bladder cancer PDOs was successfully developed.
- Morphological verification confirmed the fidelity of PDOs to original tumor tissue.
- Drug sensitivity tests demonstrated the potential of PDOs for precision medicine applications.
Conclusions:
- An initial platform for bladder tumor PDO culture was established.
- This platform supports future organoid banking and mechanistic studies.
- The findings provide a foundation for advancing precision medicine in bladder cancer treatment.
